European Drug Regulator Rules Johnson & Johnson Vaccine Use Can Continue

The European Medicines Agency has decided to continue using the Johnson & Johnson vaccine.

They ruled that the COVID-19 vaccine’s benefits outweigh the risks.

Use of that vaccine was paused after reports of very rare blood clots.

On Friday the U.S. is expected to make a decision on resuming the Johnson & Johnson vaccine.